Modeling Human BBB in vitro The first in vitro BBB models, published in the 1980s, consisted of cultured monolayers of rodent endothelial cells
Naltrexone-Bupropion: This combination medication works on the reward centers of the brain to reduce food cravings: Neurological impact While both medications affect brain function, cagrilintide's effect is more focused on appetite regulation pathways
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
Research Insight Provides valuable insights into cellular senescence and the elimination of aged cells
GHK-Cu in the morning or one night, retinoids or Vitamin C on alternate evenings
Control of IBMIR induced by fresh and cryopreserved hepatocytes by low molecular weight dextran sulfate versus heparin